CDK7-IN-30
CDK7-IN-30 (Compound 22) is a CDK7 inhibitor (IC50 = 7.21 nM) that effectively inhibits the phosphorylation of RNA Polymerase II and CDK2. CDK7-IN-30 CDK7-IN-30 can induce cell apoptosis and has anti-cancer activity and can be used in cancer research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3040999-70-7
- Fòrmula: C21H28ClN5O3S
- Peso molecular:466.00
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas DNA/RNA Synthesis
More
Actividad biológica
|
CDK7 7.21 nM (IC50) |
RNA Polymerase |
CDK9 704.3 nM (IC50) |
CDK1 >10000.00 nM (IC50) |
CDK2 734.55 nM (IC50) |
CDK3 370.40 nM (IC50) |
CDK4 644.80 nM (IC50) |
CDK5 3678.50 nM (IC50) |
CDK6 1345.50 nM (IC50) |
CDK7-IN-30 (Compound 22) demonstrates potent antiproliferative effects on cancer cells, with IC50 values of 288.0 nM (RS4;11), 174.6 nM (MM.1S), 37.5 nM (Mino), and 168.7 nM (Jeko-1), respectively. Meanwhile, CDK7-IN-30 exhibits weaker inhibitory effects on normal blood cells PBMCs, with an IC50 value of 757.9 nM[1].
CDK7-IN-30 (50-500 nM; 24 h) causes cell cycle arrest in G1/S phase and (100-1000 nM; 48 h) promotes apoptosis in MV4-11 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 3040999-70-7
-
Peso molecular 466.00
-
Fòrmula C21H28ClN5O3S
-
SMILES
CC(C)S(C(C=CC=C1)=C1NC2=NC(N[C@@H]3CC[C@H](CC3)NC(C)=O)=NC=C2Cl)(=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)